Healthcare

Sigma Healthcare Limited (ASX:SIG) announced that it has withdrawn its interest from the sale process of The Boots Group (Boots) following preliminary discussions. The company confirmed that its Board has elected to cease discussions immediately after reviewing the potential opportunity.

Over the past twelve months, CSL shares have moved by approximately -52.81%, based on the referenced closing price data. This figure is presented for descriptive context alongside the day's more modest movement.

• ImExHS supplies cloud-based medical imaging and radiology software solutions across approximately 18 countries.

• Cleo Diagnostics Ltd (ASX:COV) traded at A$0.34, up 8.06% (+A$0.025) during the trading session on 30 July 2026.• No single ASX announcement dated on or immediately before 30 July 2026 has been identified that clearly explains the share-price movement.• The company’s most recent …

Ballarat-founded Vitrafy Life Sciences (ASX: VFY) is pushing its liquid-nitrogen-free freezing platform into the US blood market. We examine the business, its cash position and the catalysts and risks for this early-commercial stock.

The trophon maker has landed CORIS's first US FDA 510(k) clearance and grown its installed base beyond 38,000 devices, but softer capital sales and a full-year 2027 launch temper the near-term story.

PolyNovo (ASX: PNV) has reported record unaudited FY26 revenue and its first positive free cash flow, but with audited profit still pending and a new leadership team, questions over durability remain.